Search Results - "SODDU, S"

Refine Results
  1. 1

    Mutant p53 gains new function in promoting inflammatory signals by repression of the secreted interleukin-1 receptor antagonist by Ubertini, V, Norelli, G, D'Arcangelo, D, Gurtner, A, Cesareo, E, Baldari, S, Gentileschi, M P, Piaggio, G, Nisticò, P, Soddu, S, Facchiano, A, Bossi, G

    Published in Oncogene (07-05-2015)
    “…The TP53 tumor-suppressor gene is frequently mutated in human cancer. Missense mutations can add novel functions (gain-of-function, GOF) that promote tumor…”
    Get full text
    Journal Article
  2. 2
  3. 3

    MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response by Mancini, F, Pieroni, L, Monteleone, V, Lucà, R, Fici, L, Luca, E, Urbani, A, Xiong, S, Soddu, S, Masetti, R, Lozano, G, Pontecorvi, A, Moretti, F

    Published in Oncogene (14-01-2016)
    “…The p53 inhibitor, MDM4 (MDMX) is a cytoplasmic protein with p53-activating function under DNA damage conditions. Particularly, MDM4 promotes phosphorylation…”
    Get full text
    Journal Article
  4. 4

    Pax8 has a critical role in epithelial cell survival and proliferation by Di Palma, T, Filippone, M G, Pierantoni, G M, Fusco, A, Soddu, S, Zannini, M

    Published in Cell death & disease (01-07-2013)
    “…The transcription factor Pax8, a member of the Paired-box gene family, is a critical regulator required for proper development and differentiation of thyroid…”
    Get full text
    Journal Article
  5. 5

    hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells by Trono, P, Di Modugno, F, Circo, R, Spada, S, Di Benedetto, A, Melchionna, R, Palermo, B, Matteoni, S, Soddu, S, Mottolese, M, De Maria, R, Nisticò, P

    Published in Oncogene (18-02-2016)
    “…Human Mena (hMENA), an actin regulatory protein of the ENA/VASP family, cooperates with ErbB receptor family signaling in breast cancer. It is overexpressed in…”
    Get full text
    Journal Article
  6. 6

    HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage by Lazzari, C, Prodosmo, A, Siepi, F, Rinaldo, C, Galli, F, Gentileschi, M, Bartolazzi, A, Costanzo, A, Sacchi, A, Guerrini, L, Soddu, S

    Published in Oncogene (01-12-2011)
    “…Homeodomain-interacting protein kinase 2 (HIPK2) is an emerging player in cell response to genotoxic agents that senses damage intensity and contributes to the…”
    Get full text
    Journal Article
  7. 7

    HIPK2 sustains apoptotic response by phosphorylating Che-1/AATF and promoting its degradation by De Nicola, F, Catena, V, Rinaldo, C, Bruno, T, Iezzi, S, Sorino, C, Desantis, A, Camerini, S, Crescenzi, M, Floridi, A, Passananti, C, Soddu, S, Fanciulli, M

    Published in Cell death & disease (11-09-2014)
    “…Che-1/AATF is an RNA polymerase II-binding protein that is involved in the regulation of gene transcription, which undergoes stabilization and accumulation in…”
    Get full text
    Journal Article
  8. 8

    High Mobility Group A1 (HMGA1) proteins interact with p53 and inhibit its apoptotic activity by Pierantoni, G M, Rinaldo, C, Esposito, F, Mottolese, M, Soddu, S, Fusco, A

    Published in Cell death and differentiation (01-09-2006)
    “…HMGA gene overexpression and rearrangements are frequent in several tumours, but their oncogenic function is still unclear. Here we report of a physical and…”
    Get full text
    Journal Article
  9. 9

    p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation by Tritarelli, A, Oricchio, E, Ciciarello, M, Mangiacasale, R, Palena, A, Lavia, P, Soddu, S, Cundari, E

    Published in Molecular biology of the cell (01-08-2004)
    “…We recently demonstrated that the p53 oncosuppressor associates to centrosomes in mitosis and this association is disrupted by treatments with…”
    Get full text
    Journal Article
  10. 10

    IMP-3 expression in keratoacanthomas and squamous cell carcinomas of the skin: an immunohistochemical study by Soddu, S, Di Felice, E, Cabras, S, Castellanos, M E, Atzori, L, Faa, G, Pilloni, L

    Published in European journal of histochemistry (14-02-2013)
    “…The protein insulin-like growth factor II mRNA binding protein 3 (IMP3) is an important factor for cell migration and adhesion in malignancies. Recent studies…”
    Get full text
    Journal Article
  11. 11

    HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage by Iacovelli, S., Ciuffini, L., Lazzari, C., Bracaglia, G., Rinaldo, C., Prodosmo, A., Bartolazzi, A., Sacchi, A., Soddu, S.

    Published in Cell proliferation (01-06-2009)
    “…Introduction/objectives:  The serine/threonine kinase homeodomain‐interacting protein kinase 2 (HIPK2) is a co‐regulator of an increasing number of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    p53 can inhibit cell proliferation through caspase-mediated cleavage of ERK2 MAPK by Marchetti, A, Cecchinelli, B, D'Angelo, M, D'Orazi, G, Crescenzi, M, Sacchi, A, Soddu, S

    Published in Cell death and differentiation (01-06-2004)
    “…Stimulation of the Ras/MAPK cascade can either activate p53 and promote replicative senescence and apoptosis, or degrade p53 and promote cell survival. Here we…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma by MATTIONI, M, SODDU, S, PORRELLO, A, D'ALESSANDRO, R, SPILA, A, GUADAGNI, F

    “…Mutations in the TP53 gene are the most common genetic alterations in cancer. Accumulation of mutated protein may induce circulating anti-p53 antibodies…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Wt-p53 action in human leukaemia cell lines corresponding to different stages of differentiation by RIZZO, M. G, ZEPPARONI, A, CRISTOFANELLI, B, SCARDIGLI, R, CRESCENZI, M, BLANDINO, G, GIULIACCI, S, FERRARI, S, SODDU, S, SACCHI, A

    Published in British journal of cancer (01-05-1998)
    “…Recent studies support the potential application of the wt-p53 gene in cancer therapy. Expression of exogenous wt-p53 suppresses a variety of leukaemia…”
    Get full text
    Journal Article
  19. 19

    Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule by BIROCCIO, A, DEL BUFALO, D, RICCA, A, D'ANGELO, C, D'ORAZI, G, SACCHI, A, SODDU, S, ZUPI, G

    Published in Gene therapy (01-06-1999)
    “…In this article, we investigated the effect induced by the reintroduction of wild-type p53 (wt-p53) protein on BCNU sensitivity in the ADF glioblastoma line…”
    Get full text
    Journal Article
  20. 20

    Expression of exogenous wt-p53 does not affect normal hematopoiesis : implications for bone marrow purging by SCARDIGLI, R, BOSSI, G, BLANDINO, C, CRESCENZI, M, SODDU, S, SACCHI, A

    Published in Gene therapy (01-12-1997)
    “…Some gene therapy approaches for cancer treatment attempt to transduce onco-suppressor genes into tumor cells. A central problem of this strategy is the…”
    Get full text
    Journal Article